Guorong Deng
Xi'an, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Corrigendum to "Inflammation-induced promoter hypermethylation of GLP-1R limits the protective effect of GLP-1R agonists against acute lung injury" [Biochem. Pharmacol. 251 (2026) 118112].
Journal: Biochemical pharmacology
Published: June 13, 2026
Inflammation-induced promoter hypermethylation of GLP-1R limits the protective effect of GLP-1R agonists against acute lung injury.
Journal: Biochemical pharmacology
Published: March 24, 2026
Remimazolam alleviates acute lung injury via translocator protein mediated inhibition of the NF-κB pathway.
Journal: European journal of pharmacology
Published: August 22, 2025
Remimazolam alleviates acute lung injury by inhibiting ferroptosis: a multi-omics system pharmacology approach with experimental validation.
Journal: European journal of medical research
Published: July 14, 2025
Inhibition of ferroptosis by serine protease inhibitor attenuates acute respiratory distress syndrome.
Journal: Archives of biochemistry and biophysics
Published: June 26, 2025
Brown adipose tissue-derived extracellular vesicles regulate hepatocyte mitochondrial activity to alleviate high-fat diet-induced jawbone osteoporosis in mice.
Journal: Frontiers in endocrinology
Published: February 25, 2025
The association of blood eosinophil levels with sepsis and mortality risk: An observational and Mendelian Randomization Study.
Journal: Journal of intensive medicine
Published: December 30, 2024
Global, regional, and national burden of myocarditis and its attributable risk factors in 204 countries and territories from 1990 to 2021: updated systematic analysis.
Journal: Frontiers in public health
Published: December 16, 2024
Remimazolam inhibits apoptosis of endothelial and epithelial cells by activating the PI3K/AKT pathway in acute lung injury.
Journal: International immunopharmacology
Published: September 16, 2024
Synergistic effects of LCN2 and TWEAK on the progression of psoriasis.
Journal: Cellular & molecular immunology
Published: June 22, 2024
Last Updated: 09/26/2026